Desenvolvimento de aplicativo mobile para optimização da avaliação da neuromodulação do sistema nervoso autônomo em pacientes com disfunção temporomandibular

Abstract

INTRODUCTION: Chronic pain is a continuous or recurrent pain lasting at least three months, which has a different biological function compared to acute pain and is associated with autonomic nervous system (ANS) hyperactivity. Temporomandibular disorders (TMD) are recognized as the most common chronic orofacial pain conditions faced by dentists and other health professionals. Modulation of the Peripheral Autonomic Nervous System (MSNAP), in turn, has been shown to be a promising therapy in the treatment of chronic pain. One of the diagnostic methodologies of MSNAP is the Peripheral Autonomic Nervous System Evaluation Method, which consists of electrothermal diagnostic therapy and also electrostimulation therapy based on the electrophysical properties of the organism and the regulation of the autonomic nervous system (ANS), making it possible to make an energy diagnosis . But it is an evaluation process still done manually which makes it time consuming, complex and liable to human error. OBJECTIVE: To develop a mobile application that will inform the therapist which channels are below or beyond the normal energy levels automatically, through the measurement by Ohimetro. METHODS: The first stage of the project consisted of planning and production. The second was the conduct of a clinical research with two different intervention groups. Group A was attended with 5 physiotherapy sessions and Group B with MSNAP, being evaluated using the developed application. RESULTS AND DISCUSSION: Twenty-four volunteers with a mean age of 30.037 ± 9.23 years, mostly female (83.33%), diagnosed with TMD were attended. Regarding the severity of the dysfunction, the majority presented moderate TMD (41.67%), but 29.17% of the sample had severe TMD and 29.16% had mild TMD. There was a higher prevalence of muscle type TMD in both intervention groups. As for pain, this was statistically reduced after the protocol application of both conventional and MSNAP therapy. Regarding the number of points, representative of the ANS, in dysfunction before and after the intervention, in the MSNA group there was a more expressive reduction. CONCLUSION: NeuroSym presents as a free and efficient technological resource in the optimization of the assessment of neuromodulation of the autonomic nervous system in patients with TMD, mitigating possible errors and optimizing evaluation time and consequently of treatment. Regarding clinical research, there was a significant reduction in both intervention groups, and a reduction in the number of representative points of the autonomic nervous system in the MSNAP group was more expressive.